Doctor shares tips to combat bad breath reported with GLP-1 drugs
[ad_1] Novo Nordisk to slash Wegovy, Ozempic list prices Board certified rheumatologist Dr. Mahsa Tehrani discusses Novo Nordisk’s decision to dramatically cut the U.S. list prices for its popular diabetes and weight-loss drugs Ozempic and Wegovy on ‘America Reports.’ NEWYou can now listen to Fox News articles! Those taking GLP-1 (glucagon-like peptide-1) medications for diabetes…
